@article{4603565cdc24441f9f61f29e3664d076,
title = "Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report",
author = "Vivek Subbiah and Hong, {David S.} and Funda Meric-Bernstam",
note = "Funding Information: The authors acknowledge The University of Texas MD Anderson Cancer Center, National Institutes of Health Cancer Center Support Grant CA016672, and Novartis for providing the drugs for the clinical trial. This work was supported in part by Cancer Prevention Research Institute of Texas Grant RP110584 and National Center for Advancing Translational Sciences Grant UL1 TR000371 (Center for Clinical and Translational Sciences).",
year = "2016",
month = mar,
day = "15",
doi = "10.1073/pnas.1522052113",
language = "English (US)",
volume = "113",
pages = "E1419--E1420",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "11",
}